Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Viral nucleoside polymerases are essential enzymes encoded by viruses that catalyze the synthesis of viral nucleic acids (DNA or RNA) using nucleoside triphosphates as substrates. These polymerases are central to viral genome replication and transcription, enabling the virus to reproduce within host cells. They differ from host cell polymerases in their structure, function, and mechanisms of initiation, and are major targets for antiviral drug development.
Incorporation of nucleoside analogs into nascent viral genomes, leading to chain termination or inhibition of further elongation.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Viral Nucleoside Polymerase (Viral Pol).